Hostname: page-component-7b7567c8c-w7t8q Total loading time: 0 Render date: 2026-11-18T11:06:32.611Z Has data issue: false hasContentIssue false

Identifying Predictive Factors of Severity in Methamphetamine-Induced Psychosis Utilizing the Positive and Negative Syndrome Scale (PANSS)

Published online by Cambridge University Press:  30 June 2026

Sidra Rasheed
Affiliation:
Faisalabad Medical University, Faisalabad, Pakistan
Imtiaz Ahmad Dogar
Affiliation:
Faisalabad Medical University, Faisalabad, Pakistan
Iqra Ain Ali
Affiliation:
Faisalabad Medical University, Faisalabad, Pakistan
Abdul Rehman Asgher
Affiliation:
Faisalabad Medical University, Faisalabad, Pakistan
Hafiza Aneeqa Mustafa
Affiliation:
Faisalabad Medical University, Faisalabad, Pakistan
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Aims:

Methamphetamine-induced psychosis (MIP) is a severe psychiatric condition increasingly reported in low- and middle-income countries like Pakistan. It manifests with positive, negative, and general psychopathological symptoms, often mimicking primary psychotic disorders. Understanding predictors of severity is crucial for early intervention and prevention of chronicity. The aim is to quantify symptom severity in MIP using the Positive and Negative Syndrome Scale (PANSS) and identify demographic and substance-use-related predictors of higher PANSS scores.

Methods:

A cross-sectional analytical study was conducted over six months at DHQ/Allied II Hospital, Faisalabad. Ninety-three adults diagnosed with MIP as per DSM–5 criteria were assessed using PANSS. Data on demographics, age of onset, duration, frequency, and route of methamphetamine use were collected. Statistical analyses included correlation, ANOVA, and multivariate linear regression (p < 0.05).

Results:

The mean total PANSS score was 88.4 ± 14.2, indicating moderate-to-severe psychosis. Negative symptoms predominated (mean=24.5). Intravenous (IV) use, onset before age 25, and use duration > 2 years were independent predictors of higher total PANSS scores (β=12.8, 7.2, and 9.4, respectively; all p < 0.01). IV users had significantly higher scores than oral or smoking users (p < 0.001).

Conclusion:

MIP in this cohort is moderately severe, with negative symptoms notably elevated. Early initiation, prolonged use, and IV administration significantly worsen psychosis severity. These modifiable risk factors highlight targets for public health interventions and early clinical screening in substance use settings.

Information

Type
Research
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists
Submit a response

eLetters

No eLetters have been published for this article.